BioAlliance Pharma Signs a Co-Promotion Agreement with Lundbeck Inc. (formerly Ovation Pharmaceuticals) for in-Hospital Prescription of the Antidepressant Seroplex(R)

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the signature of a 2009 co-promotion agreement with Lundbeck for the latter's Seroplex® antidepressant.
MORE ON THIS TOPIC